Yaso Therapeutics, Inc.
PrivateLast Round
Grant
Sep 11, 2025
Total Funding Raised
$3.18M
Company Overview
Yaso Therapeutics, Inc. is a pharmaceutical company that develops non-hormonal contraceptive and antiviral drug products for sexual health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yaso Therapeutics, Inc. Comparables
Compare Yaso Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gedea Biotech | 86% | |
| Osel Inc. | 81% | |
| Daré Bioscience Inc | 71% |
Yaso Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 11, 2025 | ||||
| Accelerator | Apr 1, 2023 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | May 1, 2006 |
Key People
Founding team and executive leadership
Yaso Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2023
Springboard Enterprises led the accelerator round.
- Sep 1, 2018
Secured $1.5M grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Yaso Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yaso Therapeutics, Inc.'s valuation, stock price, and market status.
Is Yaso Therapeutics, Inc. a public or private company?
Yaso Therapeutics, Inc. is a private company.
What is the current stock price of Yaso Therapeutics, Inc.?
Yaso Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Yaso Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yaso Therapeutics, Inc. worth (valuation)?
Valuation information for Yaso Therapeutics, Inc. is not publicly available.
Can I buy Yaso Therapeutics, Inc. stock?
Yaso Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yaso Therapeutics, Inc.'s last funding round?
Yaso Therapeutics, Inc.'s most recent funding round was Grant on September 11, 2025.
Who are the main investors in Yaso Therapeutics, Inc.?
Key investors in Yaso Therapeutics, Inc. include National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Will Yaso Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Yaso Therapeutics, Inc..
How can I track Yaso Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Yaso Therapeutics, Inc.'s shares on secondary markets.